ARCHIVES

Jill ElkenberryTo Get ACCC Award

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 17, 1989

Download PDF Visit The Full Archive

Related Articles

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

January 28, 2005

NCI To File Record No. Of INDS In ’92, Expand Phase 1 Trials

March 6, 1992

Intercultural Cancer Council Endorses New NCI Office

July 5, 1996

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

December 25, 2009

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997